Srinivas Akkaraju, Director at ZS Pharma, holds 11.91M shares in Scholar Rock Holding (Ticker: SRRK), holds 9.33K shares in Syros Pharmaceuticals (Ticker: SYRS), holds 1.70M shares in Alumis Inc. (Ticker: ALMS).
Srinivas Akkaraju latest transaction was an Uninformative Sell of $34.39M.
What was Srinivas Akkaraju's most profitable transaction?
Srinivas Akkaraju’s most profitable transaction was an Informative Buy of SRRK stock on October 18, 2023. The return on the trade was 306.20%.
What is Srinivas Akkaraju's role in ZS Pharma?
Srinivas Akkaraju's role in ZS Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.